COSCIENS Biopharma, Inc. (CSCI.TO)
8.32
-0.20
(-2.35%)
CAD |
TSX |
Nov 13, 16:00
COSCIENS Biopharma Enterprise Value : 15.23M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 15.23M |
| November 12, 2026 | 15.43M |
| November 11, 2026 | 15.43M |
| November 10, 2026 | 15.31M |
| November 09, 2026 | 15.31M |
| November 06, 2026 | 15.41M |
| November 05, 2026 | 15.31M |
| November 04, 2026 | 15.41M |
| November 03, 2026 | 15.41M |
| November 02, 2026 | 15.41M |
| October 30, 2026 | 15.31M |
| October 29, 2026 | 15.90M |
| October 28, 2026 | 15.71M |
| October 27, 2026 | 15.39M |
| October 26, 2026 | 15.61M |
| October 23, 2026 | 15.53M |
| October 22, 2026 | 15.53M |
| October 21, 2026 | 15.53M |
| October 20, 2026 | 15.51M |
| October 19, 2026 | 15.69M |
| October 16, 2026 | 16.06M |
| October 15, 2026 | 15.80M |
| October 14, 2026 | 16.50M |
| October 13, 2026 | 16.60M |
| October 09, 2026 | 16.50M |
| Date | Value |
|---|---|
| October 08, 2026 | 16.79M |
| October 07, 2026 | 16.08M |
| October 06, 2026 | 15.61M |
| October 05, 2026 | 15.78M |
| October 02, 2026 | 15.66M |
| October 01, 2026 | 15.66M |
| September 30, 2026 | 16.15M |
| September 29, 2026 | 5.105M |
| September 28, 2026 | 4.415M |
| September 25, 2026 | 4.415M |
| September 24, 2026 | 4.192M |
| September 23, 2026 | 3.778M |
| September 22, 2026 | 3.778M |
| September 21, 2026 | 3.247M |
| September 18, 2026 | 3.354M |
| September 17, 2026 | 3.194M |
| September 16, 2026 | 3.194M |
| September 15, 2026 | 3.194M |
| September 14, 2026 | 3.407M |
| September 11, 2026 | 3.407M |
| September 10, 2026 | 3.364M |
| September 09, 2026 | 3.364M |
| September 08, 2026 | 3.364M |
| September 04, 2026 | 3.141M |
| September 03, 2026 | 3.141M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Spectral Medical, Inc. | 321.20M |
| Resverlogix Corp. | 135.88M |
| Theratechnologies, Inc. | -- |
| Restart Life Sciences Corp. | 3.639M |
| Defence Therapeutics Inc | 21.82M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.823M |
| Revenue (Quarterly) | 3.522M |
| Total Expenses (Quarterly) | 8.345M |
| EPS Diluted (Quarterly) | -4.832 |
| Gross Profit Margin (Quarterly) | 54.77% |
| Profit Margin (Quarterly) | -136.9% |
| Earnings Yield | -104.2% |
| Normalized Earnings Yield | -80.70 |